Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q2VF18

Entry ID Method Resolution Chain Position Source
AF-Q2VF18-F1 Predicted AlphaFoldDB

No variants for Q2VF18

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q2VF18

No associated diseases with Q2VF18

6 regional properties for Q2VF18

Type Name Position InterPro Accession
domain Ribonuclease III domain 968 - 1131 IPR000999-1
domain Ribonuclease III domain 1153 - 1375 IPR000999-2
domain Helicase, C-terminal 412 - 582 IPR001650
domain Dicer dimerisation domain 603 - 704 IPR005034
domain DEAD/DEAH box helicase domain 65 - 228 IPR011545
domain Helicase superfamily 1/2, ATP-binding domain 59 - 257 IPR014001

Functions

Description
EC Number
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

5 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
helicase activity Catalysis of the reaction: ATP + H2O = ADP + phosphate, to drive the unwinding of a DNA or RNA helix.
metal ion binding Binding to a metal ion.
ribonuclease III activity Catalysis of the endonucleolytic cleavage of RNA with 5'-phosphomonoesters and 3'-OH termini; makes two staggered cuts in both strands of dsRNA, leaving a 3' overhang of 2 nt.
RNA binding Binding to an RNA molecule or a portion thereof.

4 GO annotations of biological process

Name Definition
defense response to virus Reactions triggered in response to the presence of a virus that act to protect the cell or organism.
gene silencing by RNA A process in which an RNA molecule reduces expression of target genes. This can occur pre-transcriptionally by assembly of heterochromatin and prevention of transcription or co- or post-transcriptionally by targeting RNAs for degradation or by interfering with splicing or translation. This process starts once the inhibitory RNA molecule has been transcribed, and includes processing of the RNA such as cleavage, modifications, transport from the nucleus to the cytoplasm, loading onto the RISC complex, and the effect on transcription or translation.
regulation of defense response to virus Any process that modulates the frequency, rate or extent of the antiviral response of a cell or organism.
RNA processing Any process involved in the conversion of one or more primary RNA transcripts into one or more mature RNA molecules.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MAYYTDSSSS ESEDFEDVIN QVVAEEDITG AAWYDGHLSE EDSPGGKPRP KEQLPKDIVK
70 80 90 100 110 120
MDARAYQLEM LEASLKENII CAMDTGSGKT HVAILRIKAE LEEMPEGQVV WFLTPTVSLC
130 140 150 160 170 180
AQQYAVVKAQ IPSVQTKIVT GADKVDSWSS TTWDGALLNV KVIITTPQVL LDALLHGFVN
190 200 210 220 230 240
ISSLALMVFD EAHHCNKNHA YSRVMKEFYW ESKTKHEPVP RILGLTASPV VRSDISSLKR
250 260 270 280 290 300
LESTLDAVCR SPTRHREELI ANSQRPALFS IIYNPKLQPY AAGFSESLTK LMAARNKLNI
310 320 330 340 350 360
LEDPYVVSLR AEISDRSRRK LEKAIKEKRT YVQDTMKSFC RRSMEMAKEL GAWAADWFIS
370 380 390 400 410 420
EAIRLFLAGI YRQGASSKSF RDAEVIFLAR VFQDANIEPP PPLTTHSGLS EKVQRIIEVL
430 440 450 460 470 480
LNYDKDARAI CFVKERATTV VLSHILTTHP EVSSKFRIGT MVGTSFVPGV KRDFLDLPET
490 500 510 520 530 540
GGSQCLEAFR EGRKNMLVAT SVLEEGIDVP ACNLIICFDK PNNLRAFIQR RGRARMRQSH
550 560 570 580 590 600
LYLFVEDEAE ADWEALEAQM KLQYEDEKRE HERLEAIENS EALDYPEELR VESTGARLTI
610 620 630 640 650 660
NDAKSHLQHF VSTLASRKFV QTQPDYLIEK VSQGYQPGDQ PLLKATVLLP VSVPQALRQV
670 680 690 700 710 720
TSSRTWVSEK NACMDAAFQA YKALYEAGLV DDHLLPLRDR LELELEVRPG MREVRGLYNP
730 740 750 760 770 780
WLSIAAACTQ GDVPLCRRAL KVSDGNNSEL CEFELAIPVA LPEMKPMVVW WDHRAQLTLR
790 800 810 820 830 840
IDSDAVMADT DVRHADQTTI NQQDHTSVLL SLAYGHRNMT IRDDCILRLV SKSGPLSMEQ
850 860 870 880 890 900
LGQVEFAPGL VTANGSSYLV RDERDQSRHP YYFESVLPSK PPAESIRKVY RGFDEDPTEA
910 920 930 940 950 960
TYLSVRKWPK KTGFFHRPCS PQHSPSTKPY AYILPAETTT VDRIPLVYAQ MGLLMPSLVC
970 980 990 1000 1010 1020
YTELYLVAAE LSRKVLAPLR ISNVSMLVEA ICAKSARTPE NYERIEFLGD SILKTCITVN
1030 1040 1050 1060 1070 1080
LAATKLHLPE GILSLMKDRL VSNARLCRAA CDAELDQFLV TQQLVTKGWQ PPYMSDLAKQ
1090 1100 1110 1120 1130 1140
DQEPESKRIL SPKTLADVVE ALIGVSFVDG GLPKALECIR LFIPESQPRP FSEVRDILFG
1150 1160 1170 1180 1190 1200
AAEPKGMKLP ADLQLLEQLI EYSFCEKALL VEAVTHPSYN VSGTVACYDR LEFIGDAILD
1210 1220 1230 1240 1250 1260
YIIVEEVFAL EPALENWQMH LLRTALVNAD ILGFLIMEWS YKQMGFEVCR ANEGDSDSKS
1270 1280 1290 1300 1310 1320
SGDSTSDKAS PRLEQTEVPI PLWSFMRQSS AELTMEREIT KARFEELRDP ILEAMRSGTH
1330 1340 1350 1360 1370 1380
YPWALFARLH AQKFYSDFFE ALVGAIWVDA GPGFDACRAF VARSGVLPYL KRLLRDQVHV
1390 1400 1410 1420 1430 1440
LHPKEELGRL AGRERVEYVV KETLKDDGDG KEWACEVRVG GRYVTDVTGC LFKEESRVKA
1450
ATQACEILKR K